in the mail order pharmacy business. Our focus is on providing convenient and cost-effective options for our customers, and it's a part of our overall strategy to improve customer experience and drive shareholder value.

In conclusion, based on the information provided in the earnings call transcript, I recommend an 'underweight' investment stance on Walgreens Boots Alliance. Despite the strong business performance and growth in key financial metrics such as sales and adjusted operating income, there are several factors that raise concerns. The impact of Rite Aid-related costs on GAAP earnings, the significant drop in GAAP net earnings attributable to Walgreens Boots Alliance, and the negative impact of the stronger U.S. dollar on sales all contribute to a less favorable outlook for the company. Furthermore, the significant costs associated with the Rite Aid acquisition and store optimization program will likely impact profitability in the short term. Additionally, the challenges in the Retail Pharmacy International division and the impact of recent hurricanes on the business add to the uncertainty. Overall, while the company's long-term growth potential may be sound, the current financial and market conditions warrant a cautious approach to investment in Walgreens Boots Alliance.